Show Search Form

Search Results

human indexable	true false
published	true false
registered interest	true false
answer date	exactly: or between: and
date	exactly: or between: and
date tabled	exactly: or between: and
ddp created	exactly: or between: and
ddp modified	exactly: or between: and
answering body
question status
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
identifier
legislature
parliament number
question first answered
question first ministerially corrected
question text
session
session number
tabling member constituency
tabling member printed
title
type
uin
version
written parliamentary question type
answer
creator	label
publisher
tabling member	label

Search

100022

human indexable
published
registered interest
answer date	21/10/2014
date	15/10/2014
date tabled	15/10/2014
ddp created	21/10/2014 12:30:06
ddp modified	08/02/2015 02:56:58
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patient Choice Schemes
house id	1
identifier	905559
legislature	25259
parliament number	55
question first answered	21/10/2014 16:00:56
question text	To ask the Secretary of State for Health, what steps he is taking to promote patient choice.
session	2014/15
session number	4
tabling member constituency	Stroud
tabling member printed	Neil Carmichael
title	House of Commons Tabled Parliamentary Question 2014/15 905559
type	WrittenParliamentaryQuestion
uin	905559
version	1
written parliamentary question type	NamedDay
answer	answer
creator	4104 label Biography information for Neil Carmichael
publisher	25259
tabling member	4104 label Biography information for Neil Carmichael

100186

human indexable
published
registered interest
answer date	23/10/2014
date	21/10/2014
date tabled	21/10/2014
ddp created	21/10/2014 21:01:13
ddp modified	08/02/2015 03:08:31
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Patients: Safety
house id	1
identifier	211233
legislature	25259
parliament number	55
question first answered	28/10/2014 15:28:25
question first ministerially corrected	28/10/2014 16:30:53
question text	To ask the Secretary of State for Health, whether missed or inadequate hydrocortisone administration is included in the NHS list of Never Events.
session	2014/15
session number	4
tabling member constituency	Oxford East
tabling member printed	Mr Andrew Smith
title	House of Commons Tabled Parliamentary Question 2014/15 211233
type	WrittenParliamentaryQuestion
uin	211233
version	1
written parliamentary question type	Ordinary
answer	answer
creator	95 label Biography information for Mr Andrew Smith
publisher	25259
tabling member	95 label Biography information for Mr Andrew Smith

100402

human indexable
published
registered interest
answer date	27/10/2014
date	22/10/2014
date tabled	22/10/2014
ddp created	22/10/2014 22:51:19
ddp modified	08/02/2015 03:30:27
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Paralysis
house id	1
identifier	211576
legislature	25259
parliament number	55
question first answered	27/10/2014 16:53:22
question text	To ask the Secretary of State for Health, what steps he has taken to support University College London in its work to enable people who have been paralysed to regain the ability to walk.
session	2014/15
session number	4
tabling member constituency	Strangford
tabling member printed	Jim Shannon
title	House of Commons Tabled Parliamentary Question 2014/15 211576
type	WrittenParliamentaryQuestion
uin	211576
version	1
written parliamentary question type	NamedDay
answer	answer
creator	4131 label Biography information for Jim Shannon
publisher	25259
tabling member	4131 label Biography information for Jim Shannon

100411

human indexable
published
registered interest
answer date	27/10/2014
date	22/10/2014
date tabled	22/10/2014
ddp created	22/10/2014 22:51:22
ddp modified	08/02/2015 03:31:28
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Cystic Fibrosis
house id	1
identifier	211584
legislature	25259
parliament number	55
question first answered	27/10/2014 16:52:12
question text	To ask the Secretary of State for Health, what steps the Government is taking to support research into new treatments for people with cystic fibrosis.
session	2014/15
session number	4
tabling member constituency	Barnsley Central
tabling member printed	Dan Jarvis
title	House of Commons Tabled Parliamentary Question 2014/15 211584
type	WrittenParliamentaryQuestion
uin	211584
version	1
written parliamentary question type	NamedDay
answer	answer
creator	4243 label Biography information for Dan Jarvis
publisher	25259
tabling member	4243 label Biography information for Dan Jarvis

100816

human indexable
published
registered interest
answer date	28/10/2014
date	23/10/2014
date tabled	23/10/2014
ddp created	23/10/2014 20:10:23
ddp modified	08/02/2015 04:00:38
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Terminal Illnesses
house id	1
identifier	211809
legislature	25259
parliament number	55
question first answered	28/10/2014 14:56:20
question text	To ask the Secretary of State for Health, what guidance his Department has issued to health technology appraisal committees on application of NICE's end of life criteria when appraising treatments for patients with terminal illness.
session	2014/15
session number	4
tabling member constituency	Redcar
tabling member printed	Ian Swales
title	House of Commons Tabled Parliamentary Question 2014/15 211809
type	WrittenParliamentaryQuestion
uin	211809
version	1
written parliamentary question type	NamedDay
answer	answer
creator	4045 label Biography information for Ian Swales
publisher	25259
tabling member	4045 label Biography information for Ian Swales

100817

human indexable
published
registered interest
answer date	28/10/2014
date	23/10/2014
date tabled	23/10/2014
ddp created	23/10/2014 20:10:23
ddp modified	08/02/2015 04:00:40
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Terminal Illnesses
house id	1
identifier	211807
legislature	25259
parliament number	55
question first answered	28/10/2014 14:27:08
question text	To ask the Secretary of State for Health, what rationale lies behind NICE's advice that end-of-life criteria should only apply to medicines that extend life by at least three months.
session	2014/15
session number	4
tabling member constituency	Redcar
tabling member printed	Ian Swales
title	House of Commons Tabled Parliamentary Question 2014/15 211807
type	WrittenParliamentaryQuestion
uin	211807
version	1
written parliamentary question type	NamedDay
answer	answer
creator	4045 label Biography information for Ian Swales
publisher	25259
tabling member	4045 label Biography information for Ian Swales

65962

human indexable
published
registered interest
answer date	09/07/2014
date	07/07/2014
date tabled	07/07/2014
ddp created	07/07/2014 23:30:25
ddp modified	07/02/2015 14:40:02
answering body	Department for Business, Innovation and Skills
question status	Tabled
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Life Sciences: Northern Ireland
house id	1
identifier	204143
legislature	25259
parliament number	55
question first answered	22/07/2014 14:48:34
question text	To ask the Secretary of State for Business, Innovation and Skills, what work the Life Science Investment Organisation is doing to promote the life sciences sector in Northern Ireland.
session	2014/15
session number	4
tabling member constituency	Bury South
tabling member printed	Mr Ivan Lewis
title	House of Commons Tabled Parliamentary Question 2014/15 204143
type	WrittenParliamentaryQuestion
uin	204143
version	1
written parliamentary question type	Ordinary
answer	answer
creator	441 label Biography information for Mr Ivan Lewis
publisher	25259
tabling member	441 label Biography information for Mr Ivan Lewis

77653

human indexable
published
registered interest
answer date	16/07/2014
date	14/07/2014
date tabled	14/07/2014
ddp created	14/07/2014 21:31:08
ddp modified	07/02/2015 17:05:38
answering body	Department for Business, Innovation and Skills
question status	Tabled
answering dept id	26
answering dept short name	Business, Innovation and Skills
answering dept sort name	Business, Innovation and Skills
hansard heading	Manufacturing Industries: Drugs
house id	1
identifier	205633
legislature	25259
parliament number	55
question first answered	28/08/2014 15:54:58
question text	To ask the Secretary of State for Business, Innovation and Skills, what steps his Department is taking to encourage international pharmaceutical companies to locate in the UK.
session	2014/15
session number	4
tabling member constituency	Salisbury
tabling member printed	John Glen
title	House of Commons Tabled Parliamentary Question 2014/15 205633
type	WrittenParliamentaryQuestion
uin	205633
version	2
written parliamentary question type	Ordinary
answer	answer
creator	4051 label Biography information for John Glen
publisher	25259
tabling member	4051 label Biography information for John Glen

78736

human indexable
published
registered interest
answer date	21/07/2014
date	17/07/2014
date tabled	17/07/2014
ddp created	17/07/2014 18:51:02
ddp modified	07/02/2015 18:34:39
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Meningitis: Vaccination
house id	1
identifier	206537
legislature	25259
parliament number	55
question first answered	02/09/2014 13:40:37
question text	To ask the Secretary of State for Health, whether the Bexsero vaccine is licensed for (a) individual application and (b) use in conjunction with other vaccines.
session	2014/15
session number	4
tabling member constituency	The Cotswolds
tabling member printed	Geoffrey Clifton-Brown
title	House of Commons Tabled Parliamentary Question 2014/15 206537
type	WrittenParliamentaryQuestion
uin	206537
version	1
written parliamentary question type	Ordinary
answer	answer
creator	249 label Biography information for Sir Geoffrey Clifton-Brown
publisher	25259
tabling member	249 label Biography information for Sir Geoffrey Clifton-Brown

78909

human indexable
published
registered interest
answer date	22/07/2014
date	18/07/2014
date tabled	18/07/2014
ddp created	18/07/2014 16:20:32
ddp modified	07/02/2015 18:49:28
answering body	Department of Health
question status	Tabled
answering dept id	17
answering dept short name	Health
answering dept sort name	Health
hansard heading	Parkinson's Disease
house id	1
identifier	206600
legislature	25259
parliament number	55
question first answered	03/09/2014 09:44:33
question text	To ask the Secretary of State for Health, how many incidents of medication errors involving hospital patients with Parkinson's disease have been reported since the joint patient safety alert on steps to improve data reporting quality was issued by NHS England and the Medicines and Healthcare Products Regulatory Agency in March 2014.
session	2014/15
session number	4
tabling member constituency	Newcastle upon Tyne North
tabling member printed	Catherine McKinnell
title	House of Commons Tabled Parliamentary Question 2014/15 206600
type	WrittenParliamentaryQuestion
uin	206600
version	1
written parliamentary question type	Ordinary
answer	answer
creator	4125 label Biography information for Catherine McKinnell
publisher	25259
tabling member	4125 label Biography information for Catherine McKinnell